Tarbox Family Office’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-138
Closed -$5K 1118
2021
Q4
$5K Hold
138
﹤0.01% 616
2021
Q3
$7K Hold
138
﹤0.01% 557
2021
Q2
$6K Hold
138
﹤0.01% 598
2021
Q1
$7K Hold
138
﹤0.01% 476
2020
Q4
$7K Hold
138
﹤0.01% 462
2020
Q3
$5K Hold
138
﹤0.01% 486
2020
Q2
$4K Hold
138
﹤0.01% 539
2020
Q1
$4K Hold
138
﹤0.01% 477
2019
Q4
$4K Buy
+138
New +$3.29K ﹤0.01% 585

Other funds holding NEO

Tarbox Family Office's NEO Position: Q1 2022 in Review

Tarbox Family Office sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 138 shares — an estimated $5K sold.

Tarbox Family Office first reported a position in NEO in Q4 2019 and held it in 9 quarters. The position peaked at $7K in Q3 2021. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Tarbox Family Office reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Tarbox Family Office sold 138 NeoGenomics shares in Q1 2022, an estimated $5K.
  • Tarbox Family Office first reported a position in NeoGenomics in Q4 2019 and held it in 9 quarters.
  • Tarbox Family Office's NeoGenomics position peaked at $7K in Q3 2021.
  • 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Tarbox Family Office's 13F filing for Q1 2022, filed 25 Apr 2022.